Journal: ACS medicinal chemistry letters
Article Title: Diversity-Oriented Synthesis as a Strategy for Fragment Evolution against GSK3?.
PMID/MRN: 27660690
Publication Date: 2016-Sep-08
Abstract:
Traditional fragment-based drug discovery (FBDD) relies heavily on structural analysis of the hits bound to their targets. Herein, we present a complementary approach based on diversity-oriented synthesis (DOS). A DOS-based fragment collection was able to produce initial hit compounds against the target GSK3?, allow the systematic synthesis of related fragment analogues to explore fragment-level structure-activity relationship, and finally lead to the synthesis of a more potent compound.